Chronopharmaceutics: an Overview
Year: 2026
Type: article
Abstract: Chronopharmaceutics is an significant branch of pharmaceutics concentrated on designing drug-delivery systems that release therapeutic agents according to biological rhythms and the time-dependent requirements of the body.[1,4,7] Circadian rhythms influence several physiological, biochemical, pharmacokinetic, and pathological processes, along with blood pressure, hormone secretion, gastric acid secretion, inflammatory activity, drug absorption, metabolism, and elimination. Consequently, maintaining a constant drug concentration does not always provide a constant therapeutic effect. Chronotherapeutic drug delivery systems (CDDS) overcome this limitation by synchronizing drug release with the time when disease activity or therapeutic requirements are foremost. This analysis characterizes the basic principles, classification, mechanisms, applications, advantages, and recent advances in chronopharmaceutical drug delivery. Major CDDS approaches comprises pulsatile, time-controlled, osmotic, stimuli-responsive, multiparticulate, site-specific, and programmable systems. These systems includes predetermined lag period followed by rapid, delayed, or controlled drug release. Important technologies such as OROS®, CODAS®, CEFORM®, DIFFUCAPS®, PULSINCAP® and three-dimensional printing-based systems. Their drug-release mechanisms involve diffusion, dissolution, erosion, hydration, osmotic pressure, polymeric barriers, and responses to physiological or external stimuli. Chronopharmaceutical systems have promising applications in diseases manifesting predictable circadian patterns, such as bronchial asthma, cardiovascular diseases, arthritis, peptic and duodenal ulcers, hypercholesterolemia, diabetes mellitus, cerebrovascular disorders, pain, sleep disorders, and cancer. Simultaneous drug availability with disease activity may enhance therapeutic efficacy, reduce unwanted drug exposure and adverse effects, decrease dosing frequency, and enhance patient compliance and adherence. Recent innovations in multiparticulate drug delivery, three-dimensional printing, personalized medicine, and automated drug-delivery technologies have additionally expanded the potential of chronotherapy. Incorporation of circadian biology with pharmacokinetics, pharmacodynamics, formulation science, and personalized medicine may support the development of safer and more efficient treatment strategies. Further research and well-designed clinical studies are mandatory to establish the therapeutic benefits and broader clinical application of chronopharmaceutical drug-delivery systems.[10,11,13,15]
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Keywords: chronotherapy, circadian rhythm, pulsatile drug release, time-controlled drug release, osmotic drug delivery, stimuli-responsive drug delivery, multiparticulate dosage forms, three-dimensional printing, personalized medicine, automated drug delivery, drug release mechanism, medication adherence
Open Access status: green
OpenAlex ID: W7236451906
